Carotid atherosclerosis in patients with rheumatoid arthritis and rheumatoid nodules

Reumatologia Clinica

Volumn 9, Issue 3, 2013, Pages 136-141

  Galarza Delgado, Dionicio Angel ^a   Esquivel Valerio, Jorge Antonio ^a   Garza Elizondo, Mario Alberto ^a   Góngora Rivera, Fernando ^a   Muñoz De Hoyos, Jorge Luis ^a   Serna Peña, Griselda ^a  

^a HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

Author keywords

Atherosclerosis; Cardiovascular disease; Carotid plaque; Intima media thickness; Rheumatoid arthritis

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; METHOTREXATE; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CROSS-SECTIONAL STUDY; DIGESTIVE TRACT PARAMETERS; DISEASE ASSOCIATION; DOPPLER FLOWMETRY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBSERVATIONAL STUDY; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SUBCUTANEOUS NODULE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RHEUMATOID NODULE; YOUNG ADULT;

EID: 84877103029     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2012.07.006     Document Type: Article

References (60)

1. O'Dell J.R. Rheumatoid arthritis: the clinical picture. Textbook of rheumatology 2005, Lippincott Williams and Williams, Philadelphia, USA.
2. Pincus T. Assessment of long-term outcomes of rheumatoid arthritis. How choices of measures and study designs may lead to apparently different conclusions. Rheum Dis Clin North Am 1995, 21:619-654.
3. Pinals R.S. Survival in rheumatoid arthritis. Arthritis Rheum 1987, 30:473-475.
4. Mitchell D.M., Spitz P.W., Young D.Y., Bloch D.A., McShane D.J., Fries J.F. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum 1986, 29:706-714.
5. Erhardt C.C., Mumford P.A., Venables P.J., Maini R.N. Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study. Ann Rheum Dis 1989, 48:7-13.
6. Reilly P.A., Cosh J.A., Maddison P.J., Rasker J.J., Silman A.J. Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients. Ann Rheum Dis 1990, 49:363-369.
7. Pincus T., Callahan L.F. Taking mortality in rheumatoid arthritis seriously-predictive markers socioeconomic status comorbidity. J Rheumatol 1986, 13:841-845.
8. Vandenbroucke J.P., Hazevoet H.M., Cats A. Survival and cause of death in rheumatoid arthritis: a 25-year prospective followup. J Rheumatol 1984, 11:158-161.
9. Wolfe F., Mitchell D.M., Sibley J.T., Fries J.F., Bloch D.A., Williams C.A., et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994, 37:481-494.
10. Doran M.F., Pond G.R., Crowson C.S., O'Fallon W.M., Gabriel S.E. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 2002, 46:625-631.
11. Cobb S., Anderson F., Bauer W. Length of life and cause of death in rheumatoid arthritis. N Engl J Med 1953, 249:553-556.
12. Isomaki H.A., Mutru O., Koota K. Death rate and causes of death in patients with rheumatoid arthritis. Scand J Rheumatol 1975, 4:205-208.
13. Monson R.R., Hall A.P. Mortality among arthritics. J Chronic Dis 1976, 29:459-467.
14. Allebeck P. Increased mortality in rheumatoid arthritis. Scand J Rheumatol 1982, 11:81-86.
15. Pincus T., Callahan L.F., Sale W.G., Brooks A.L., Payne L.E., Vaughn W.K. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984, 27:864-872.
16. Symmons D.P., Prior P., Scott D.L., Brown R., Hawkins C.F. Factors influencing mortality in rheumatoid arthritis. J Chronic Dis 1986, 39:137-145.
17. Allebeck P., Ahlbom A., Allander E. Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificate. Eleven-year follow-up of an epidemiological study. Scand J Rheumatol 1981, 10:301-306.
18. Prior P., Symmons D.P., Scott D.L., Brown R., Hawkins C.F. Cause of death in rheumatoid arthritis. Br J Rheumatol 1984, 23:92-99.
19. Mutru O., Laakso M., Isomaki H., Koota K. Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J (Clin Res Ed) 1985, 290:1797-1799.
20. Jacobsson L.T., Knowler W.C., Pillemer S., Hanson R.L., Pettitt D.J., Nelson R.G., et al. Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians. Arthritis Rheum 1993, 36:1045-1053.
21. Myllykangas-Luosujarvi R., Aho K., Kautiainen H., Isomaki H. Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol 1995, 22:1065-1067.
22. Bhatt D.L., Topol E.J. Need to test the arterial inflammation hypothesis. Circulation 2002, 106:136-140.
23. Choy E.H., Panayi G.S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001, 344:907-916.
24. Del Rincon I., Freeman G.L., Haas R.W., O'Leary D.H., Escalante A. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum 2005, 52:3413-3423.
25. Del Rincon I., Williams K., Stern M.P., Freeman G.L., O'Leary D.H., Escalante A. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 2003, 48:1833-1840.
26. Del Rincon I.D., Williams K., Stern M.P., Freeman G.L., Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001, 44:2737-2745.
27. Escalante A., Galarza-Delgado D., Beardmore T.D., Baethge B.A., Esquivel-Valerio J., Marines A.L., et al. Cross-cultural adaptation of a brief outcome questionnaire for Spanish-speaking arthritis patients. Arthritis Rheum 1996, 39:93-100.
28. Farragher T.M., Bruce I.N. Cardiovascular risk in inflammatory rheumatic diseases: loose ends and common threads. J Rheumatol 2006, 33:2105-2107.
29. Solomon D.H., Curhan G.C., Rimm E.B., Cannuscio C.C., Karlson E.W. Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum 2004, 50:3444-3449.
30. Pasceri V., Yeh E.T. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 1999, 100:2124-2126.
31. Manzi S., Wasko M.C. Inflammation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis 2000, 59:321-325.
32. Asanuma Y., Kawai S., Aoshima H., Kaburaki J., Mizushima Y. Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis. Arthritis Rheum 1999, 42:443-447.
33. Wallberg-Jonsson S., Ohman M.L., Dahlqvist S.R. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in northern Sweden. J Rheumatol 1997, 24:445-451.
34. Turesson C., McClelland R.L., Christianson T.J., Matteson E.L. Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 2007, 66:70-75.
35. Goodson N.J., Wiles N.J., Lunt M., Barrett E.M., Silman A.J., Symmons D.P. Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 2002, 46:2010-2019.
36. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002, 347:1557-1565.
37. Goodson N.J., Symmons D.P., Scott D.G., Bunn D., Lunt M., Silman A.J. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum 2005, 52:2293-2299.
38. Salonen R., Salonen J.T. Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study. Atherosclerosis 1990, 81:33-40.
39. Kawamori R., Yamasaki Y., Matsushima H., Nishizawa H., Nao K., Hougaku H., et al. Prevalence of carotid atherosclerosis in diabetic patients. Ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care 1992, 15:1290-1294.
40. Yamasaki Y., Kawamori R., Matsushima H., Nishizawa H., Kodama M., Kajimoto Y., et al. Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes 1994, 43:634-639.
41. Khoury Z., Schwartz R., Gottlieb S., Chenzbraun A., Stern S., Keren A. Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound. Am J Cardiol 1997, 80:1429-1433.
42. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., Wolfson S.K. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular health study collaborative research group. N Engl J Med 1999, 340:14-22.
43. Park Y.B., Ahn C.W., Choi H.K., Lee S.H., In B.H., Lee H.C., et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 2002, 46:1714-1719.
44. Gorman J.D., David-Vaudey E., Pai M., Lum R.F., Criswell L.A. Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis. Arthritis Rheum 2004, 50:3476-3484.
45. Sharp J.T., Calkins E., Cohen A.S., Schubart A.F., Calabro J.J. Observations on the clinical, chemical, and serological manifestations of rheumatoid arthritis, based on the course of 154 cases. Medicine (Baltimore) 1964, 43:41-58.
46. Gonzalez-Juanatey C., Llorca J., Garcia-Porrua C., Martin J., Gonzalez-Gay M.A. Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis. Arthritis Rheum 2006, 55:150-153.
47. Del Porto F., Laganà B., Lai S., Nofroni I., Tinti F., Vitale M., et al. Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis. Rheumatology (Oxford) 2007, 46:1111-1115.
48. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
49. Pinals R.S., Masi A.T., Larsen R.A. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981, 24:1308-1315.
50. Touboul P.J., Hennerici M.G., Meairs S., Adams H., Amarenco P., Bornstein N., et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the advisory board of the 3rd and 4th watching the risk symposium, 13th and 15th European stroke conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007, 23:75-80.
51. Roman M.J., Moeller E., Davis A., Paget S.A., Crow M.K., Lockshin M.D., et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med 2006, 144:249-256.
52. Haffner S.M., Hazuda H.P., Mitchell B.D., Patterson J.K., Stern M.P. Increased incidence of type II diabetes mellitus in Mexican Americans. Diabetes Care 1991, 14:102-108.
53. Jacobsson L.T., Turesson C., Nilsson J.A., Petersson I.F., Lindqvist E., Saxne T., et al. Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis. Ann Rheum Dis 2007, 66:670-675.
54. Jacobsson L.T., Turesson C., Gulfe A., Kapetanovic M.C., Petersson I.F., Saxne T., et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 2005, 32:1213-1218.
55. Sihvonen S., Korpela M., Mustia A., Mustonen J. The predictive value of rheumatoid factor isotypes, anti-cyclic citrullitanted peptide antibodies, and antineutrophil cytoplasmatic antibodies for mortality inpatients with rheumatoid arthritis. J Rheumatol 2005, 32:2089-2094.
56. Ortega-Hernandez O.D., Pineda-Tamayo R., Pardo A.L., Rojas-Villarraga A., Anaya J.M. Cardiovascular disease is associated with extra-articular manifestations in patients with rheumatoid arthritis. Clin Rheumatol 2009, 28:767-775.
57. Naranjo A., Sokka T., Descalzo M.A., Calvo-Alén J., Hørslev-Petersen K., Luukkainen R.K., et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther 2008, 10:R30. QUEST-RA Group.
58. Hjeltnes G., Hollan I., Førre Ø., Wiik A., Mikkelsen K., Agewall S. The presence of anti-CCP antibodies and RF IgM was related to impaired endothelial function independent of other cardiovascular risk factors in RA patients. Scand J Rheumatol 2011, 40:422-427.
59. Gonzalez-Juanatey C., Llorca J., Testa A., Revuelta J., Garcia-Porrua C., Gonzalez-Gay M.A. Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore) 2003, 82:407-413.
60. Gonzalez-Gay M.A., Gonzalez-Juanatey C., Piñeiro A., Garcia-Porrua C., Testa A., Llorca J. High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 2005, 32:1219-1223.